Pharmaceutical giant GSK has filed a lawsuit against Moderna, claiming that Moderna’s mRNA vaccines infringe on patents developed by GSK. GSK asserts that its groundbreaking mRNA vaccine platform, pioneered over a decade ago, is the foundation for Moderna’s successful vaccines. This lawsuit highlights a major battle over intellectual property rights in the rapidly developing field of mRNA vaccines, with implications for future vaccine development and the global fight against infectious diseases.